Chandan Healthcare Ltd
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
- Market Cap ₹ 505 Cr.
- Current Price ₹ 207
- High / Low ₹ 358 / 184
- Stock P/E 18.5
- Book Value ₹ 68.5
- Dividend Yield 0.00 %
- ROCE 22.8 %
- ROE 19.0 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 102% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 86.9 days to 166 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of Nifty SME Emerge
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 67 | 56 | 72 | 76 | 100 | 129 | 157 | |
| 60 | 51 | 69 | 67 | 74 | 92 | 110 | |
| Operating Profit | 6 | 5 | 3 | 9 | 25 | 37 | 46 |
| OPM % | 9% | 9% | 4% | 12% | 25% | 29% | 30% |
| 0 | 0 | 0 | 0 | 1 | 1 | 1 | |
| Interest | 2 | 2 | 2 | 2 | 2 | 4 | 4 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 6 | 10 |
| Profit before tax | 2 | 1 | -1 | 5 | 21 | 28 | 34 |
| Tax % | 39% | 45% | 93% | 23% | 24% | 26% | 25% |
| 1 | 1 | -1 | 4 | 16 | 21 | 25 | |
| EPS in Rs | 0.71 | 0.41 | -0.68 | 2.02 | 8.01 | 8.50 | 10.36 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 27% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 102% |
| 3 Years: | 89% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 25% |
| Last Year: | 19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 24 | 24 |
| Reserves | 4 | 5 | 3 | 7 | 21 | 96 | 143 |
| 15 | 14 | 15 | 17 | 29 | 33 | 39 | |
| 20 | 18 | 22 | 26 | 23 | 23 | 26 | |
| Total Liabilities | 59 | 56 | 59 | 70 | 93 | 177 | 232 |
| 20 | 20 | 25 | 28 | 44 | 71 | 96 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 4 | 12 |
| Investments | 20 | 11 | 14 | 15 | 13 | 10 | 24 |
| 19 | 25 | 21 | 27 | 37 | 91 | 100 | |
| Total Assets | 59 | 56 | 59 | 70 | 93 | 177 | 232 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -7 | 7 | 5 | 6 | -19 | 24 | ||
| 7 | -10 | -2 | -15 | -36 | -50 | ||
| -0 | -2 | -2 | 9 | 60 | 23 | ||
| Net Cash Flow | 0 | -4 | 1 | -1 | 6 | -3 | |
| Free Cash Flow | -7 | 1 | -0 | -13 | -57 | -17 | |
| CFO/OP | -121% | 274% | 61% | 37% | -31% | 70% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 76 | 53 | 77 | 80 | 88 | 103 |
| Inventory Days | 88 | 78 | 37 | 9 | 204 | ||
| Days Payable | 126 | 224 | 233 | 399 | 127 | ||
| Cash Conversion Cycle | 15 | -69 | -143 | -314 | 80 | 88 | 181 |
| Working Capital Days | -66 | -10 | -60 | -67 | -14 | 108 | 166 |
| ROCE % | 9% | 2% | 18% | 41% | 28% | 23% |
Insights
In beta| Mar 2023 | Mar 2024 | Sep 2025 | |
|---|---|---|---|
| Geographic Presence (States) Number |
|
||
| Number of Diagnostic Centres Number |
|||
| Total Patient Count Lakhs |
|||
| Total Tests Conducted Lakhs |
|||
| Number of Collection Centres Number |
|||
| Number of Pharmacy Stores Number |
|||
| Pathology Tests Offered Number |
|||
| Radiology Tests Offered Number |
|||
| Revenue per patient INR |
|||
Extracted by Screener AI
Documents
Announcements
-
General Updates
18 June 2026 - Chandan Healthcare replied to ROC complaint over DIMSL dispute, disputed ₹54.64 crore call notices and allegations.
-
General Updates
18 June 2026 - Chandan Healthcare replied to NSE complaint over RHP disclosures; cited arbitration and disputed unpaid call money claims.
-
General Updates
18 June 2026 - Company received ROC notice on complaint dated 20 May 2026 and will submit responses within timeline.
-
General Updates
16 June 2026 - Received ROC complaint notice dated 20 May 2026; response to be filed within stipulated timeline.
-
Analysts/Institutional Investor Meet/Con. Call Updates
3 June 2026 - FY26 earnings call transcript: revenue 280.67 Cr, PAT 27.06 Cr, expansion and PPP project updates.
Concalls
-
Jun 2026TranscriptPPTREC
-
Feb 2026Transcript PPT
-
Dec 2025Transcript PPT
-
Nov 2025TranscriptPPT REC
-
Aug 2025TranscriptAI SummaryPPT
Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points